Anthony Mancini
Chief Global Commercialization Officer · 8 filings · Latest: Sep 24, 2026
Revolution Medicines, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
RVMD | Anthony Mancini | Chief Global Commercialization Officer | Mar 25, 2026 | Sale | $95.56 | 37,450 | $3.6M | 54,400 | |
RVMD | Anthony Mancini | Chief Global Commercialization Officer | Mar 25, 2026 | Option Exercise | $33.62 | 37,450 | $1.3M | 91,850 | |
RVMD | Mancini Anthony | — | Mar 25, 2026 | Proposed Sale | $95.56 | 37,450 | $3.6M | — |
← Previous
Page 2 of 2